香港股市今日盘中，科济药业-B（02171.HK）股价出现显著上涨，截至14时01分，该股涨幅达5.10%，引发市场关注。
消息面上，科济药业-B于8月14日发布了2025年中期业绩报告，财务数据显示公司业绩明显改善。报告期内，公司收益达5096.1万元，同比大幅增长703.8%；毛利攀升至2936.9万元，同比增长约17.16倍。尽管公司仍处于亏损状态，但净亏损已显著收窄至7548.3万元，同比减少78.53%，每股亏损降至0.14元。
科济药业-B表示，亏损减少主要得益于研发开支和行政开支的减少，以及外汇收益净额的上升和毛利的增加。这些积极因素显示公司正在有效控制成本，同时提升营收能力，为未来的盈利奠定基础。投资者对公司业绩改善的强烈反应，反映了市场对科济药业-B未来发展前景的信心增强，推动了股价的显著上涨。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.